Biopolym. Cell. 1995; 11(6):57-61.
Synthesis and characterization of fluorogenic peptide substrate of HIV-1 protease based on fluorescence resonance energy transfer
1Kornelyuk A. I., 1Terentiev A. G., 2Fisher S., 2Porter T.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
  2. SmithKline Beecham plc,
    USA

Abstract

Synthesis of fluorogenic peptide substrate of HIV-I protease Dns-SQNYPIVWL which corresponds to the p17/p24 cleavage site for HIV-l protease have been performed. This fluorogenic substrate was based on the fluorescence resonance energy transfer between donor – Trp residue, and acceptor – dansyl group in the intact peptide. Hydrolysis of substrate by recombinant HIV-I protease resulted in the time-dependent increase of Trp fluorescence and decrease of dansyl fluorescence measured at 350 and 500 nm, respectively, due to the break of resonance energy transfer between donor and acceptor fluorophors. Hydrolysis of fluorogenic peptide substrate was studied also by reversed phase HPLC and two peptide fragments after cleavage of substrate have been detected. Kinetic constants of hydrolysis for this fluorogenic peptide substrate by HIV-I protease were calculated from Lineweaver – Burk plots: KM - 29mkM, kcat =5.4 s–1 and kcat / KM -180000 M–1s–1.

References

[1] Krausslich HG, Wimmer E. Viral proteinases. Annu Rev Biochem. 1988;57:701-54.
[2] Wlodawer A, Miller M, Jask?lski M, Sathyanarayana BK, Baldwin E, Weber IT, Selk LM, Clawson L, Schneider J, Kent SB. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science. 1989;245(4918):616-21.
[3] Kohl NE, Emini EA, Schleif WA, Davis LJ, Heimbach JC, Dixon RA, Scolnick EM, Sigal IS. Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci U S A. 1988;85(13):4686-90.
[4] Mitsuya H, Yarchoan R, Broder S. Molecular targets for AIDS therapy. Science. 1990;249(4976):1533-44.
[5] Meek TD. Inhibitors of HIV-1 protease. J Enzyme Inhib. 1992;6(1):65-98.
[6] Wlodawer A, Erickson JW. Structure-based inhibitors of HIV-1 protease. Annu Rev Biochem. 1993;62:543-85.
[7] Craig JC, Duncan IB, Whittaker L, Roberts NA. Antiviral synergy between inhibitors of HIV proteinase and reverse transcriptase. Antiviral Chem. Chemother. 1993;4: 161-6.
[8] Tomaszek TA Jr, Magaard VW, Bryan HG, Moore ML, Meek TD. Chromophoric peptide substrates for the spectrophotometric assay of HIV-1 protease. Biochem Biophys Res Commun. 1990;168(1):274-80.
[9] Matayoshi ED, Wang GT, Krafft GA, Erickson J. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science. 1990;247(4945):954-8.
[10] Wang GT, Matayoshi E, Jan Huffaker H, Krafft GA. Design and synthesis of new fluorogenic HIV protease substrates based on resonance energy transfer. Tetrahedron Letters. 1990;31(45):6493–6.
[11] Geohegan KF, Spencer RW, Danley DE, Contillo LG Jr, Andrews GC. Fluorescence-based continuous assay for the aspartyl protease of human immunodeficiency virus-1. FEBS Lett. 1990;262(1):119-22.
[12] Wu P, Brand L. Resonance energy transfer: methods and applications. Anal Biochem. 1994;218(1):1-13.
[13] Latt SA, Auld DS, Vallee BL. Fluorescende determination of carboxypeptidase A activity based on electronic energy transfer. Anal Biochem. 1972;50(1):56-62.
[14] Meek TD, Dayton BD, Metcalf BW, Dreyer GB, Strickler JE, Gorniak JG, Rosenberg M, Moore ML, Magaard VW, Debouck C. Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease. Proc Natl Acad Sci U S A. 1989;86(6):1841-5.
[15] Gershkovich AA, Kibirev V.K. Synthesis of peptides. Reagents and methods. Kiev: Naukova dumka, 1987; 264 p.
[16] Roeske RW, Gesellchen PD. Reaction of potassium salts of boc amino acids with chloromethyl polystyrene catalyzed by 18-crown-6. Tetrahedron Letters. 1976;17(38):3369–72.
[17] Filippova I. Yu., Lysogorskaya E. N., Oksenoit E. S., Komarov Yu. E., Stepanov V. M. Intramolecularly quenched fluorescent substrates for aspartic proteinases. Russian Journal of Bioorganic Chemistry. 1986; 12 (9):1172-1180.
[18] Darke PL, Nutt RF, Brady SF, Garsky VM, Ciccarone TM, Leu CT, Lumma PK, Freidinger RM, Veber DF, Sigal IS. HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins. Biochem Biophys Res Commun. 1988;156(1):297-303.